Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Thomas

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Cancer|October 11, 2008
Outcome of adults with acute lymphocytic leukemia after second salvage therapySusan O'Brien, Deborah Thomas, Farhad Ravandi, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemiaYesid Alvarado, Apostolia Tsimberidou, Hagop Kantarjian, et al.
Leukemia & Lymphoma|January 19, 2010
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remissionHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Journal of Pediatric and Adolescent Gynecology|August 5, 2023
A Multimodal Qualitative Approach to Understanding Menstrual Health Equity among Adolescents and Young AdultsShelby Davies, Kaja Darien, Farnaz Bazyar, et al.
Pharmacoepidemiology and Drug Safety|December 25, 2010
Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic usersElaine H Morrato, Benjamin G Druss, Daniel M Hartung, et al.
Cancer|August 26, 2010
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission durationHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Leukemia & Lymphoma|February 28, 2007
A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phaseAlfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Cancer|September 13, 2007
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failureJorge Cortes, Alfonso Quintás-Cardama, Guillermo Garcia-Manero, et al.
Blood|February 22, 2003
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndromeJorge Cortes, Patricia Ault, Charles Koller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemiaHagop M Kantarjian, Moshe Talpaz, Jorge Cortes, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Cancer|October 11, 2008
Outcome of adults with acute lymphocytic leukemia after second salvage therapySusan O'Brien, Deborah Thomas, Farhad Ravandi, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemiaYesid Alvarado, Apostolia Tsimberidou, Hagop Kantarjian, et al.
Leukemia & Lymphoma|January 19, 2010
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remissionHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Journal of Pediatric and Adolescent Gynecology|August 5, 2023
A Multimodal Qualitative Approach to Understanding Menstrual Health Equity among Adolescents and Young AdultsShelby Davies, Kaja Darien, Farnaz Bazyar, et al.
Pharmacoepidemiology and Drug Safety|December 25, 2010
Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic usersElaine H Morrato, Benjamin G Druss, Daniel M Hartung, et al.
Cancer|August 26, 2010
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission durationHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Leukemia & Lymphoma|February 28, 2007
A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phaseAlfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Cancer|September 13, 2007
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failureJorge Cortes, Alfonso Quintás-Cardama, Guillermo Garcia-Manero, et al.
Blood|February 22, 2003
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndromeJorge Cortes, Patricia Ault, Charles Koller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemiaHagop M Kantarjian, Moshe Talpaz, Jorge Cortes, et al.
Pageof 16